Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain
- PMID: 1464766
- PMCID: PMC6575781
- DOI: 10.1523/JNEUROSCI.12-12-04766.1992
Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain
Abstract
The mechanism by which cholinergic neurons degenerate in Alzheimer's disease is not known. Some of these neurons depend, however, on trophic support from NGF via a membrane receptor. We have analyzed the state of these receptors by autoradiography, with 125I-NGF as the ligand, in the caudate nucleus, putamen, ventral striatum, nucleus basalis of Meynert, and nucleus tegmenti pedunculopontinus of six patients with Alzheimer's disease and five controls, matched for age and postmortem delay. The binding characteristics were similar in the striatum (including caudate nucleus, putamen, and ventral striatum) and basal forebrain of control subjects and patients with Alzheimer's disease (Kd = 2.5-4 x 10(-11) M). In control brains, high levels of 125I-NGF binding were observed in the basal forebrain and striatum (0.32-0.49 fmol/mg tissue equivalent), but no specific binding was detected in the nucleus tegmenti pedunculopontinus. NGF binding sites were distributed heterogeneously in the striatum with patches of low density, corresponding to AChE-poor striosomes, surrounded by a matrix in which receptor density was significantly greater. In Alzheimer's disease, the density of NGF receptors was markedly decreased in the caudate nucleus, putamen, ventral striatum, and nucleus basalis of Meynert. In contrast, AChE staining decreased less in the nucleus basalis of Meynert in all Alzheimer's disease patients, and in the ventral striatum of those most severely affected. These results indicate that if NGF receptors are located on cholinergic neurons, receptor loss and the consequent decrease in trophic support may precede cell degeneration in Alzheimer's disease. The relationship between the loss of these receptors and the pathogenesis of the disease remains to be determined.
Similar articles
-
Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):1-8. doi: 10.1159/000106594. Dement Geriatr Cogn Disord. 1997. PMID: 8997546
-
Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease.Exp Neurol. 1997 May;145(1):245-52. doi: 10.1006/exnr.1997.6443. Exp Neurol. 1997. PMID: 9184126
-
Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.Exp Neurol. 1997 Jul;146(1):91-103. doi: 10.1006/exnr.1997.6504. Exp Neurol. 1997. PMID: 9225742
-
Neurotrophin receptors and selective loss of cholinergic neurons in Alzheimer disease.Mol Chem Neuropathol. 1996 May-Aug;28(1-3):219-23. doi: 10.1007/BF02815225. Mol Chem Neuropathol. 1996. PMID: 8871962 Review.
-
Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction.Prog Brain Res. 1996;109:253-64. doi: 10.1016/s0079-6123(08)62109-3. Prog Brain Res. 1996. PMID: 9009714 Review.
Cited by
-
Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction.Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547. Curr Alzheimer Res. 2021. PMID: 34911424 Free PMC article. Review.
-
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.Cereb Cortex. 2016 Jun;26(6):2411-2426. doi: 10.1093/cercor/bhv062. Epub 2015 Apr 2. Cereb Cortex. 2016. PMID: 25840425 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical